We appreciate your interest in our education, research, and clinical programs. Established in the early 1960's as the first independent department of radiation oncology based in a U.S. medical school, our program is an integral component of the OHSU Knight Cancer Institute, an NCI-Designated Clinical Cancer Center.
Over the past half century, my predecessors and I, including Drs. William Allen (1964-1972), William Moss (1972-1989), and Kenneth Stevens (1989-2005), have collectively led the training multiple generations of practicing radiation medicine physicians.
The Department was one of the first to publish a large experience of preoperative radiotherapy for rectal cancer, now considered part of combined-modality standard of care for this common tumor.
The Department's graduates have consistently performed in the upper quartile of the American Board of Radiology certification examinations.
In addition to maintaining our high standard of patient care, our program is singularly aligned with the long-term goals of the Knight Cancer Institute leadership as the only academic health center in the state of Oregon. Simply put, we are committed to training the next generation of leaders in academic radiation medicine. The interdisciplinary nature of cancer medicine is consistent with a culture of collaboration across specialties, departments, schools, and institutions.
Several of the pioneering contributions of the department are listed here and some of the firsts for the department are listed here
I welcome you to check out our website and to contact us for more information about our Department. Within this dynamic academic enterprise of robust clinical, educational, and research initiatives, resides a diverse community of scholars and clinicians who work in concert with some of the most dedicated radiation medicine staff in the Pacific Northwest.
I look forward to welcoming you to OHSU and sharing our Department with you.
With warmest professional regards, I am
Charles R. Thomas, Jr., M.D.
Charles R. Thomas, Jr., M.D., department chair, has been selected to serve on the Special Expert panel for the NCI Gastrointestinal Steering Committee (GISC). The role of the GISC is to implement an efficient and transparent process that will identify and promote the "Best Science" in clinical research of adult gastrointestinal cancers by addressing the design and prioritization of phase 3 trials and large phase 2 studies within the National Clinical Trials Network (NCTN).
The GISC membership is composed of representatives from the NCTN gastrointestinal disease committees, the NCI Community Oncology Research Program (NCORP), and Specialized Programs of Research Excellence (SPOREs), along with biostatisticians, patient advocates, NCI staff, and other experts in gastrointestinal cancers. The steering committee provides a forum for critical review of concepts for new trials by a broad spectrum of experts from across the NCI-supported clinical trials enterprise. The roster and more information is available at the GISC member roster
Charles R. Thomas Jr. M.D., department chair, and the Department of Radiation Medicine was recognized by the U.S. National Guard and Reserve with the Above and Beyond Award, the Patriotic Employer Award and the Seven Seals Award “for meritorious leadership and initiative in support of the men and women who serve America.” Learn more about this honor here
Charles R. Thomas, Jr, M.D., department chair, has been awarded the inaugural SWOG Cancer Research Network Mentorship Award. This award is given to an individual who goes “above and beyond basic responsibility/job description to provide mentorship, leadership training, and support for the next generation.” Learn more about Dr. Thomas and his mentorship here
Charles R. Thomas, Jr, M.D., department chair, has been selected to serve on the Internal Coordinating Committee for Region 5 of the Geographic Management of Cancer Health Disparities program (GMaP). GMaP is funded by the National Cancer Institute’s Center to Reduce Cancer Health Disparities. Through a systematic and comprehensive approach, we collaborate, cooperate, share resources and information, and build capacity between researchers, trainees, outreach workers and organizations to advance research and training.
Charles Thomas, Jr., M.D., Chair, was a visiting professor in the at Mayo Clinic Radiation Oncology's Alix of Medicine in Scottsdale., AZ in February 2020. Following a presentation on “Thymic Neoplasms: Update 2020”, he visited with house staff, faculty, students, and toured the particle therapy center.
Charles R. Thomas, Jr., department chair, attended the 2020 RSNA Clinical Trials Methodology Course. The six-day workshop, provided participants with the tools and expertise to develop protocols for clinical evaluation of imaging modalities and become funded principal investigator for clinical trials. Dr. Thomas also had the opportunity to met with former mentee, David Fuller, M.D., Ph.D., and his mentees.
Charles Thomas, Jr., M.D., Chair, discussed the challenges and solutions to establishing a mutually respectful workplace with Colin Weekes, M.D., Ph.D. during the 2019 ASCO Annual Meeting. The discussion was recorded for the ASCO Daily News podcast.
Charles Thomas, Jr., M.D., Jr., to participate in ASTRO panel, Burnout and Work-Life Balance in Radiation Oncology
Charles Thomas, Jr., M.D., Jr explains the career benefits of attending the AACHARLES/ECCO Methods in Cancer Clinical Research (MCCHARLES) workshops
Charles Thomas, Jr., M.D. co-authors survey of burnout in postgraduate radiation oncology trainees
Charles Thomas, Jr., M.D., Jr. serves a discussant for poster session at the 2017 ASCO meeting on June 3, 2017 in Chicago
Charles Thomas, Jr., M.D. moderate the 2017 ASCO Annual Meeting Grant Writing Workshop
Charles Thomas, Jr., M.D., Jr. will co-lead the ARRO Poster Walk session
Charles Thomas, Jr., M.D., Jr. was a keynote presenter at the 47th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar
Department chair, Charles Thomas, Jr., M.D., Jr., will moderate a Panel Session for the 59th ASTRO Annual Meeting
Charles Thomas, Jr., M.D., Jr., presents at the 47th Annual UF Radiation Oncology Outcomes Tracking Seminar
Drs. Nabavizadeh and Thomas on JAMA network viewpoint : Oncology Know No Borders
Charles Thomas, Jr., M.D., a visiting professor in the dept. of radiation oncology at University of Pittsburgh
Drs. Shusana Rana & Charles Thomas review micro RNA lab data from experiments in the Anand Lab
Charles Thomas, Jr., M.D. visiting NW Feinberg Medical School presenting & interfacing
Career Development in Academic Radiation Oncology. Editors: Chandra, Ravi A., Vapiwala, Neha, Thomas, Jr., Charles R.
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR Jr, Minsky BD, Ludmir EB. Mayo Clin Proc. 2021 Feb;96(2):420-426. doi: 10.1016/j.mayocp.2020.08.015.
Patterns of Care and Barriers to Utilization of Definitive Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer in Russia. Dengina N, Chernykh M, Degnin C, Chen Y, Tsimafeyeu I, Karaseva VV, Tjulandin S, Laktionov K, Thomas CR Jr, Mitin T. J Cancer Educ. 2021 Feb 2. doi: 10.1007/s13187-021-01966-8.
Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN). Coyne CJ, Reyes-Gibby CC, Durham DD, Abar B, Adler D, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Yeung SJ, Caterino JM. . Support Care Cancer. 2021 Jan 22. doi: 10.1007/s00520-021-05987-3.
Increasing Rate of Unintentional Firearm Deaths in Youngest Americans: Firearm Prevalence and Covid-19 Pandemic Implication. Bleyer A, Siegel SE, Thomas, CR. Journal of the National Medical Association, 2021, https://doi.org/10.1016/j.jnma.2020.12.005.
The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease. Boniface C, Deig C, Halsey C, Kelley T, Heskett MB, Thomas CR Jr., Spellman PT, Nabavizadeh N. Diagnostics. 2021; 11(1):73. doi.org/10.3390/diagnostics11010073
Mentorship initiatives in radiation oncology: A scoping review of the literature. Marsiglio JA, Rosenberg DM, Rooney MK, Goodman CR, Gillespie EF, Hirsch AE, Holliday EB, Kimple RJ, Thomas CR Jr, Golden DW. Int J Radiat Oncol Biol Phys. 2021 Jan 4:S0360-3016(20)34745-3. doi: 10.1016/j.ijrobp.2020.12.049.
Mentorship initiatives in radiation oncology: A scoping review of the literature. Marsiglio JA, Rosenberg DM, Rooney MK, Goodman CR, Gillespie EF, Hirsch AE, Holliday EB, Kimple RJ, Thomas, CR, Golden DW. International Journal of Radiation Oncology, Biology, Physics. 30 December 2020. https://doi.org/10.1016/j.ijrobp.2020.12.049
Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer. DuRoss AN, Landry MR, Thomas CR, Neufeld MJ, Sun C. Cancer Lett. 2020 Nov 21:S0304-3835(20)30618-2. doi: 10.1016/j.canlet.2020.11.021. Epub ahead of print. PMID: 33232787.
Linguistic Biases in Letters of Recommendation for Radiation Oncology Residency Applicants from 2015 to 2019. Chapman BV, Rooney MK, Ludmir EB, De La Cruz D, Salcedo A, Pinnix CC, Das P, Jagsi R, Thomas CR Jr, Holliday EB. J Cancer Educ. 2020 Oct 27:1–8. doi: 10.1007/s13187-020-01907-x.
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, Kelly P, Newman NB, Jeffrey Olsen J, Raldow AC, Ruiz-Garcia E, Stitzenberg KB, Thomas CR, Wu J, Das P. Practical Radiation Oncology. 2020 Oct 20; 1-13. doi:https://doi.org/10.1016/j.prro.2020.08.004
Performance Status Restriction in Phase III Cancer Clinical Trials. Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalicv D, Verma V, VanderWalde NA, Smith BD, Smith, GL. Fuller C, Das P, Minsky BD, Rödel C, Fokas E, Jagsi, R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw, 18(10), 1322-1326.
Meeting the Challenge of Scientific Dissemination in the Era of COVID-19: Toward a Modular Approach to Knowledge-Sharing for Radiation Oncology. Fuller CD,van Dijk LV, Thompson RF, Scott JG, Ludmir EB, Thomas CR. Scientific Communication, Volume 108, Issue 2, P496-505, October 01, 2020. doi:https://doi.org/10.1016/j.ijrobp.2020.06.066
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB.Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20.PMID: 32702645
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD, Thomas CR Jr.CA Cancer J Clin. 2020 Jul 19. doi: 10.3322/caac.21626
Structural Solutions for the Rarest of the Rare — Underrepresented-Minority Faculty in Medical Subspecialties. Doll KM, Thomas Jr CR. N Engl J Med 2020; 383:283-285. doi: 10.1056/NEJMms2003544
I Can’t Breathe: The Continued, Disproportionate Exclusion of Black Physicians in the United States Radiation Oncology Workforce . Deville Jr C, Cruickshank Jr I, Chapman CH, Hwang W-T, Wyse R, Ahmed AA, Winkfield K, Thomas Jr CR, Gibbs IC. International Journal of Radiation Oncology • Biology • Physics (2020), doi: https://doi.org/10.1016/j.ijrobp.2020.07.015
Radiation Oncology Study Guide. Chandra RA, Ord CB, Rana S, Hansen EK, Thomas, CR. (Eds.) Springer Nature. 2nd ed. 2021, Approx. 450 p. 50 illus. in color.
What Happens Next: Radiation Oncology After COVID? Chandra RA, Thomas CR. Clinical & Translational Radiation Oncology. 26 May 2020. doi: https://doi.org/10.1016/j.ctro.2020.05.009
Longitudinal Health-Related Quality of Life among Individuals Considering Treatment for Stage I Non-Small Cell Lung Cancer. Nugent SM, Golden SE, Hooker ER, Sullivan DR, Thomas CR Jr, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Samson P, Robinson C, Slatore CG; Early Stage Lung Cancer Comparative Effectiveness Research Consortium. Ann Am Thorac Soc. 2020 May 20. doi: 10.1513/AnnalsATS.202001-029OC. Epub ahead of print.
Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise. Mitin T, Dengina N, Chernykh M, Usychkin S, Gladkov O, Degnin C, Chen Y, Nosov D, Tsimafeyeu I, Thomas CR Jr, Tjulandin S. J Cancer Educ. 2020 Mar 4. doi: 10.1007/s13187-020-01728-y
Advocating for a "Community to bench model" in the 21st century. Tossas KY, Watson KS, Colditz GA, Thomas CR, Stewart JH, Winn RA. EBioMedicine. 2020 Feb 26;53:102688. doi: 10.1016/j.ebiom.2020.102688
Real-world applications of deep convolutional neural networks in diagnostic cancer imaging. Elhalawani H, Yang P, Abazeed M, Shah C, Mohamed ASR, Thomas CR Jr, Fuller CD, Thompson RF. Chin Clin Oncol. 2020 Feb 1. pii: cco.2020.01.02. doi: 10.21037/cco.2020.01.02.
Disease Sites. Chandra RA, Kachnic LA, Thomas CR Jr. Hematol Oncol Clin North Am. 2020 Feb;34(1):xv-xvi. doi: 10.1016/j.hoc.2019.09.011. Epub 2019 Oct 28.
Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise. Mitin T, Degnin C, Chen Y, Shirvani S, Gillespie E, Hoffe S, Latifi K, Nabavizadeh N, Dengina N, Chernich M, Usychkin S, Kharitonova E, Egorova Y, Pankratov A, Tsimafeyeu I, Thomas CR Jr, Tjulandin S, Likhacheva A.
In Regard to Wallner et al. Kang J, Thompson RF, Fuller CD, Camphausen KA, Gabriel PE, Thomas CR. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):217-218. doi: 10.1016/j.ijrobp.2019.10.044.
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology. Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. J Natl Cancer Inst. 2019 Dec 1;111(12):1358-1360. doi: 10.1093/jnci/djz117.
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR Jr, Fuller CD, VanderWalde NA. J Geriatr Oncol. 2019 Nov 8. pii: S1879-4068(19)30348-0. doi: 10.1016/j.jgo.2019.11.001.
Bridging the Gap in Global Advanced Radiation Oncology Training: Impact of a Web-Based Open-Access Interactive Three-Dimensional Contouring Atlas on Radiation Oncologist Practice in Russia. McClelland S 3rd, Chernykh M, Dengina N, Gillespie EF, Likhacheva A, Usychkin S, Pankratov A, Kharitonova E, Egorova Y, Tsimafeyeu I, Tjulandin S, Thomas CR Jr, Mitin T. J Cancer Educ. 2019 Oct;34(5):871-873. doi: 10.1007/s13187-018-1388-7.
Validation of the Emergency Severity Index (Version 4) for the Triage of Adult Emergency Department Patients With Active Cancer. Adler D, Abar B, Durham DD, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Coyne CJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Yeung SJ, Caterino JM. J Emerg Med. 2019 Sep;57(3):354-361. doi: 10.1016/j.jemermed.2019.05.023. Epub 2019 Jul 26.
Enhancing chemoradiation of colorectal cancer through targeted delivery of raltitrexed by hyaluronic acid coated nanoparticles. Rosch JG, Landry MR, Thomas CR Jr, Sun C. Nanoscale. 2019 Aug 7;11(29):13947-13960. doi: 10.1039/c9nr04320a. Epub 2019 Jul 15.
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. Beeler WH, Griffith KA, Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Thomas CR Jr, Jagsi R. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):979-986. doi: 10.1016/j.ijrobp.2019.01.074. Epub 2019 Jan 23.
Treatment-Related Complications of Systemic Therapy and Radiotherapy. Jairam V, Lee V, Park HS, Thomas CR Jr, Melnick ER, Gross CP, Presley CJ, Adelson KB, Yu JB. JAMA Oncol. 2019 Jul 1;5(7):1028-1035. doi: 10.1001/jamaoncol.2019.0086.
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD. JAMA Oncol. 2019 Jun 3. doi: 10.1001/jamaoncol.2019.2055.
Stop hedging your bets: reasons for non-adherence to a tri-modality regimen in the treatment of esophageal cancer in a multidisciplinary setting. Rahmani R, Koffler D, Haisley KR, Hunter JG, Poliakoff C, Thomas CR Jr, Holland JM, Dolan JP, Nabavizadeh N. J Gastrointest Oncol. 2019 Jun;10(3):387-390. doi: 10.21037/jgo.2019.01.24.
Use of the g-index for assessment of citation-based scholarly activity of United States radiation oncology residents and subsequent choice of academic versus private practice career. McClelland Iii S, Mitin T, Nabavizadeh N, Fuller CD, Thomas CR Jr, Jaboin JJ. Rep Pract Oncol Radiother. 2019 May-Jun;24(3):294-297. doi: 10.1016/j.rpor.2019.03.005.
Radiation oncology crossword: Genitourinary cancer. McClelland S 3rd, Mitin T, Thomas CR Jr. Rep Pract Oncol Radiother. 2019 May-Jun;24(3):281-283. doi: 10.1016/j.rpor.2019.03.004.
Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy. DuRoss AN, Neufeld MJ, Landry MR, Rosch JG, Eaton CT, Sahay G, Thomas CR Jr, Sun C. ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12342-12356. doi: 10.1021/acsami.9b02408.
Integrating nanomedicine into clinical radiotherapy regimens. DuRoss AN, Neufeld MJ, Rana S, Thomas CR Jr, Sun C. Adv Drug Deliv Rev. 2019 Apr;144:35-56. doi: 10.1016/j.addr.2019.07.002
Is Watch-and-Wait Ready for Prime Time?: It Depends on Priming of the Multidisciplinary Care Team. Thomas CR Jr. JAMA Oncol. 2019 Apr 1;5(4):e185895. doi: 10.1001/jamaoncol.2018.5895.
Analysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency Departments. Caterino JM, Adler D, Durham DD, Yeung SJ, Hudson MF, Bastani A, Bernstein SL, Baugh CW, Coyne CJ, Grudzen CR, Henning DJ, Klotz A, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Venkat A, Wilson J, Thomas CR Jr, Bischof JJ, Lyman GH. JAMA Netw Open. 2019 Mar 1;2(3):e190979. doi: 10.1001/jamanetworkopen.2019.0979.
Artificial Intelligence in Oncology: Current Applications and Future Directions. Kann BH, Thompson R, Thomas CR Jr, Dicker A, Aneja S. Oncology (Williston Park). 2019 Feb 15;33(2):46-53.
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients. Stinchcombe TE, Fan W, Schild SE, Vokes EE, Bogart J, Le QT, Thomas CR, Edelman MJ, Horn L, Komaki R, Cohen HJ, Kishor Ganti A, Pang H, Wang X. Cancer. 2019 Feb 1;125(3):382-390. doi: 10.1002/cncr.31813.
Industry Funding Is Correlated With Publication Productivity of US Academic Radiation Oncologists. Zaorsky NG, Ahmed AA, Zhu J, Yoo SK, Fuller CD, Thomas CR Jr, Choi M, Holliday EB. J Am Coll Radiol. 2019 Feb;16(2):244-251. doi: 10.1016/j.jacr.2018.07.024.
Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology. Thompson RF, Fuller CD, Berman AT, Aneja S, Thomas CR Jr. JCO Clin Cancer Inform. 2019 Feb;3:1-4. doi: 10.1200/CCI.18.00126.
An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR Jr, Okunieff P, Fuller CD. Clin Transl Radiat Oncol. 2019 Jan 6;15:83-92. doi: 10.1016/j.ctro.2019.01.001
Establishing a Mutually Respectful Environment in the Workplace: A Toolbox for Performance Excellence. Duma N, Maingi S, Tap WD, Weekes CD, Thomas CR Jr. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e219-e226. doi: 10.1200/EDBK_249529.
Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns. Farrell MJ, Yahya JB, Degnin C, Chen Y, Holland JM, Henderson MA, Jaboin JJ, Harkenrider MM, Thomas CR Jr, Mitin T. Clin Lung Cancer. 2019 Jan;20(1):13-19. doi: 10.1016/j.cllc.2018.08.015.
Survey results of US radiation oncology providers' contextual engagement of watch-and-wait beliefs after a complete clinical response to chemoradiation in patients with local rectal cancer. Yahya J, Herzig D, Farrell M, Degnin C, Chen Y, Holland J, Brown S, Binder C, Jaboin J, Tsikitis VL, Nabavizadeh N, Thomas CR Jr, Mitin T. J Gastrointest Oncol. 2018 Dec;9(6):1127-1132. doi: 10.21037/jgo.2018.08.02